united health care semaglutide Medicare's new $50 weight-loss drug program: Who qualifies and what are the concerns? Semaglutide Safety Questions

Small wins keep you motivated

Compounded medications are not FDA-approved, and their safety or effectiveness has not been independently confirmed by the FDA

Although these findings are preliminary, some mechanistic models posit that GLP-1s could attenuate DMN activity associated with food-related rumination, potentially altering the cognitive context in which eating decisions occur

Price cuts for this class of drugs would generally be welcome news, as GLP-1 medications are highly effective at promoting weight loss and improving cardiometabolic health, as well as preventing diabetes and heart, kidney disease and liver disease

Early but unfulfilled promise Semaglutide is the active ingredient in the diabetes drug Ozempic and the obesity medication Wegovy